K.J. Harrison & Partners’s Briacell Therapeutics BCTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-580
| Closed | -$249K | – | 190 |
|
2024
Q1 | $249K | Buy |
580
+42
| +8% | +$18K | 0.04% | 188 |
|
2023
Q4 | $476K | Buy |
538
+97
| +22% | +$85.8K | 0.08% | 163 |
|
2023
Q3 | $411K | Buy |
441
+210
| +91% | +$196K | 0.09% | 110 |
|
2023
Q2 | $217K | Sell |
231
-475
| -67% | -$446K | 0.04% | 197 |
|
2023
Q1 | $785K | Sell |
706
-2,145
| -75% | -$2.39M | 0.16% | 136 |
|
2022
Q4 | $2.52M | Sell |
2,851
-348
| -11% | -$308K | 0.49% | 68 |
|
2022
Q3 | $2.75M | Sell |
3,199
-7,515
| -70% | -$6.46M | 0.97% | 27 |
|
2022
Q2 | $9.19M | Buy |
10,714
+1,702
| +19% | +$1.46M | 2.48% | 6 |
|
2022
Q1 | $13.7M | Buy |
+9,012
| New | +$13.7M | 2.21% | 8 |
|